Article info

Download PDFPDF

Original research
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

Authors

  • Frank Jühling Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Nourdine Hamdane Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Emilie Crouchet Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Shen Li Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Houssein El Saghire Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Atish Mukherji Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Naoto Fujiwara Liver Tumor Translational Research Program, Harold C. Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Marine A Oudot Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Christine Thumann Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Antonio Saviano Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Strasbourg, France PubMed articlesGoogle scholar articles
  • Armando Andres Roca Suarez Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Kaku Goto Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Ricard Masia Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Mozhdeh Sojoodi Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Gunisha Arora Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hiroshi Aikata Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Atsushi Ono Liver Tumor Translational Research Program, Harold C. Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Parissa Tabrizian Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Myron Schwartz Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Stephen J Polyak Department of Global Health, University of Washington, Seattle, Washington, USA Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Irwin Davidson Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/UDS, Illkirch, France PubMed articlesGoogle scholar articles
  • Christian Schmidl CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria Regensburg Centre for Interventional Immunology (RCI), Regensburg, Germany PubMed articlesGoogle scholar articles
  • Christoph Bock CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Catherine Schuster Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Kazuaki Chayama Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Patrick Pessaux Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Strasbourg, France PubMed articlesGoogle scholar articles
  • Kenneth K Tanabe Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Yujin Hoshida Liver Tumor Translational Research Program, Harold C. Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Mirjam B Zeisel Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL), Lyon, France PubMed articlesGoogle scholar articles
  • François HT Duong Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France PubMed articlesGoogle scholar articles
  • Bryan C Fuchs Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Thomas F Baumert Université de Strasbourg, Strasbourg, France Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Strasbourg, France Institut Universitaire de France (IUF), Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Prof Thomas F Baumert, Inserm U1110, Strasbourg 67000, France; Thomas.Baumert{at}unistra.fr
View Full Text

Citation

Jühling F, Hamdane N, Crouchet E, et al
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

Publication history

  • Received April 17, 2019
  • Revised March 5, 2020
  • Accepted March 5, 2020
  • First published March 26, 2020.
Online issue publication 
February 19, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.